Page 528 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer
P. 528

Appendix Table C4.3. Comparison between watchful waiting and radiation therapy (continued)
                                        Author, Year       Study name      Comparison  Outcome               Followup      Sample size        Results                             Factors included in the
                                        [Pubmed ID]        /Database                       definition/       (yr)          per group                                              model
                                                                                           measurement
                                        Study design                                       instrument
                                        Thong 224          Eindhoven       RT vs. “AS”     General QoL:      Mean 8 yr     RT: 71             RT was negatively associated        Matching: cancer stage,
                                        2009               Cancer                          SF-36 scores                    AS: 71             with physical functioning and       tumor
                                        19747357           Registry                                                                           bodily pain dimensions of the       grade, age at diagnosis (
                                                           (ECR)                           Expanded                                           SF-36, spiritual and total          ±2 yrs), and number of
                                        Retrospective                                      Prostate                                           wellbeing scores of the QoL-        years since diagnosis (±2
                                        matched cohort                                     Cancer Index                                       CS, and bowel function and          yrs).
                                                                                           (EPIC):                                            bowel bother of EPIC index.
                                                                                           urinary and                                                                            Multivariate model adjusted
                                                                                           bowel                                              No other significant                for comorbidity and disease
                                                                                           functioning,                                       associations between general        progression
                                                                                           and urinary                                        QoL, cancer-specific QoL, or
                                                                                           and bowel                                          disease-specific QoL scores
                                                                                           bother                                             and management strategy (RT
                                                                                                                                              vs. “AS”).
                                                                                           Quality of Life
                                                                                           – Cancer
                                                                                           Survivors
                                                                                           (QOL-CS)






































                                                                                                                        C-182
   523   524   525   526   527   528   529   530   531   532   533